VIDHU GUPTA

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology BLUE BELL, PA NPI 1760423792

General Payments — all program years on this page

$3,899.43

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 159
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $279.48 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $279.4812

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
TG THERAPEUTICS, INC. $71.823
NOVARTIS PHARMACEUTICALS CORPORATION $61.223
Genentech USA, Inc. $30.121
ABBVIE INC. $27.671
PFIZER INC. $24.321
Amneal Pharmaceuticals LLC $23.981
ARGENX US, INC. $23.631
UCB, Inc. $16.721

By program year

Program yearAmountRecords
2018 $643.0031
2019 $991.5763
2020 $734.9022
2021 $921.5020
2022 $52.484
2023 $276.507
2024 $279.4812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086922113 Novartis Pharmaceuticals Corporation $28.40 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086922117 Novartis Pharmaceuticals Corporation $16.29 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086922137 Novartis Pharmaceuticals Corporation $16.53 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103854039 ABBVIE INC. $27.67 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131952018 PFIZER INC. $24.32 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133129435 Genentech USA, Inc. $30.12 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136892016 TG Therapeutics, Inc. $22.34 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136892074 TG Therapeutics, Inc. $28.57 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136892130 TG Therapeutics, Inc. $20.91 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139187890 Amneal Pharmaceuticals LLC $23.98 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142124067 ARGENX US, INC. $23.63 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143127114 UCB, Inc. $16.72 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.